MOUNTAIN VIEW, Calif., Dec. 7, 2019 /PRNewswire/ -- Ceribell, Inc announced the launch of Clarity, a new 24/7 bedside EEG monitoring and alerting technology, at the American Epileptology Society ...
Ceribell, Inc. CBLL recently announced that it has received FDA clearance for the Clarity algorithm for use in pediatric patients. This breakthrough expands the utility of Ceribell’s rapid ...
Powered by Clarity, the Ceribell System will enable rapid, bedside detection, diagnosis and treatment of non-convulsive seizures in children experiencing neurological emergencies SUNNYVALE, Calif., ...
—Five abstracts presented at the 2024 Neurocritical Care Society Annual Meeting demonstrated the clinical impact of the FDA-cleared Ceribell System and Ceribell's AI-powered Clarity™ algorithm— ...
SUNNYVALE, Calif., April 15, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with ...
Based on Ceribell’s assessment, its Clarity algorithm now provides coverage across the largest age range ever addressed by a seizure detection technology. This offers hospitals, particularly emergency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback